The impact of escalating regulatory requirements on the conduct of clinical research

Bruce Geoffrey Gordon, Anne Kessinger, S. L. Mann, E. D. Prentice

Research output: Contribution to journalReview article

6 Citations (Scopus)

Abstract

A discussion of the impact of escalating regulatory requirements is provided, from the point of view of the administration of the institutional review board of an academic institution, and from clinical investigators who conduct studies at that same institution. Current and anticipated future issues are discussed.

Original languageEnglish (US)
Pages (from-to)309-313
Number of pages5
JournalCytotherapy
Volume5
Issue number4
DOIs
StatePublished - Jan 1 2003

Fingerprint

Research Ethics Committees
Research Personnel
Research

Keywords

  • Clinical research
  • Regulatory issues

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology
  • Oncology
  • Genetics(clinical)
  • Cell Biology
  • Transplantation
  • Cancer Research

Cite this

The impact of escalating regulatory requirements on the conduct of clinical research. / Gordon, Bruce Geoffrey; Kessinger, Anne; Mann, S. L.; Prentice, E. D.

In: Cytotherapy, Vol. 5, No. 4, 01.01.2003, p. 309-313.

Research output: Contribution to journalReview article

Gordon, Bruce Geoffrey ; Kessinger, Anne ; Mann, S. L. ; Prentice, E. D. / The impact of escalating regulatory requirements on the conduct of clinical research. In: Cytotherapy. 2003 ; Vol. 5, No. 4. pp. 309-313.
@article{4e3ed28678c443c0b072aab6297dca3c,
title = "The impact of escalating regulatory requirements on the conduct of clinical research",
abstract = "A discussion of the impact of escalating regulatory requirements is provided, from the point of view of the administration of the institutional review board of an academic institution, and from clinical investigators who conduct studies at that same institution. Current and anticipated future issues are discussed.",
keywords = "Clinical research, Regulatory issues",
author = "Gordon, {Bruce Geoffrey} and Anne Kessinger and Mann, {S. L.} and Prentice, {E. D.}",
year = "2003",
month = "1",
day = "1",
doi = "10.1080/14653240310002225",
language = "English (US)",
volume = "5",
pages = "309--313",
journal = "Cytotherapy",
issn = "1465-3249",
publisher = "Informa Healthcare",
number = "4",

}

TY - JOUR

T1 - The impact of escalating regulatory requirements on the conduct of clinical research

AU - Gordon, Bruce Geoffrey

AU - Kessinger, Anne

AU - Mann, S. L.

AU - Prentice, E. D.

PY - 2003/1/1

Y1 - 2003/1/1

N2 - A discussion of the impact of escalating regulatory requirements is provided, from the point of view of the administration of the institutional review board of an academic institution, and from clinical investigators who conduct studies at that same institution. Current and anticipated future issues are discussed.

AB - A discussion of the impact of escalating regulatory requirements is provided, from the point of view of the administration of the institutional review board of an academic institution, and from clinical investigators who conduct studies at that same institution. Current and anticipated future issues are discussed.

KW - Clinical research

KW - Regulatory issues

UR - http://www.scopus.com/inward/record.url?scp=0142063069&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0142063069&partnerID=8YFLogxK

U2 - 10.1080/14653240310002225

DO - 10.1080/14653240310002225

M3 - Review article

VL - 5

SP - 309

EP - 313

JO - Cytotherapy

JF - Cytotherapy

SN - 1465-3249

IS - 4

ER -